Ultragenyx Pharma (RARE) PT Lowered to $33 at Cantor Fitzgerald

September 3, 2026 6:35 AM

Cantor Fitzgerald analyst Kristen Kluska lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $33.00 (from $103.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found